Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cognitive impairment in the schizophrenia spectrum: exploring the relationships of the g-factor with sociodemography, psychopathology, neurodevelopment, and genetics.
Yeh D, He Q, Krebs E, Iftimovici A, Martinez G, Bourgin-Duchesnay J, Mouaffak F, Danset-Alexandre C, de Gasquet M, Jantac C, Bendjemaa N, Chaumette B, Krebs MO, Scoriels L. Yeh D, et al. Among authors: he q. Psychol Med. 2024 Dec 2:1-12. doi: 10.1017/S0033291724002538. Online ahead of print. Psychol Med. 2024. PMID: 39620480
Chinese expert consensus on transoral vestibular approach robotic thyroidectomy and parathyroidectomy (version 2024).
He Q, Tian W, Wang P, Wang X; Expert Working Group on Thyroid Surgery, Chinese Medical Doctor Association Division of Surgeons, Thyroid Disease Committee of Chinese Research Hospital Association, General Surgery Branch of China International Exchange, Promotive Association for Medical, Health Care. He Q, et al. J Robot Surg. 2024 Dec 2;19(1):15. doi: 10.1007/s11701-024-02173-5. J Robot Surg. 2024. PMID: 39617782 Review.
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study.
Iyer SP, Sica RA, Ho PJ, Prica A, Zain J, Foss FM, Hu B, Beitinjaneh A, Weng WK, Kim YH, Khodadoust MS, Huen AO, Williams LM, Ma A, Huang E, Ganpule A, Nagar SD, Sripakdeevong P, Cullingford EL, Karnik S, Dequeant ML, Patel JN, He XS, Li Z, He QA, Mendonez JH, Keegan A, Horwitz SM. Iyer SP, et al. Among authors: he qa. Lancet Oncol. 2024 Nov 28:S1470-2045(24)00508-4. doi: 10.1016/S1470-2045(24)00508-4. Online ahead of print. Lancet Oncol. 2024. PMID: 39617017
13,564 results
You have reached the last available page of results. Please see the User Guide for more information.